Table 2.
Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age | 56 | ||||
≥65 | 38 | Reference | |||
<65 | 18 | 1.338 (0.653 - 2.743) | 0.427 | ||
Gender | 56 | ||||
male | 47 | Reference | |||
female | 9 | 1.339 (0.547 - 3.276) | 0.522 | ||
Tumor size | 56 | ||||
≥4 | 29 | Reference | |||
<4 | 27 | 1.708 (0.838 - 3.483) | 0.141 | ||
Grade | 56 | ||||
High | 51 | Reference | |||
Low | 5 | 0.722 (0.171 - 3.041) | 0.657 | ||
pT-stage | 56 | ||||
≥T2 | 41 | Reference | |||
<T2 | 15 | 0.819 (0.367 - 1.830) | 0.627 | ||
pTNM-Stage | 56 | ||||
>II | 30 | Reference | Reference | ||
≤II | 26 | 0.418 (0.200 - 0.872) | 0.020 | 0.640 (0.282 - 1.454) | 0.286 |
External aggression | 56 | ||||
yes | 5 | Reference | Reference | ||
No | 51 | 0.355 (0.135 - 0.931) | 0.035 | 0.768 (0.240 - 2.451) | 0.655 |
Lymph node metastasis | 56 | ||||
yes | 9 | Reference | Reference | ||
No | 47 | 0.441 (0.188 - 1.033) | 0.060 | 0.822 (0.290 - 2.330) | 0.712 |
PRPF19 expression |
56 | ||||
High | 36 | Reference | Reference | ||
Low | 20 | 0.219 (0.082 - 0.580) | 0.002 | 0.274 (0.099 - 0.758) | 0.013 |